{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:49:59Z","timestamp":1760042999041,"version":"3.37.3"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1124\/jpet.103.061259","type":"journal-article","created":{"date-parts":[[2004,2,25]],"date-time":"2004-02-25T22:12:55Z","timestamp":1077747175000},"page":"1102-1110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Acute Cardiovascular Effects of Sibutramine in Conscious Rats"],"prefix":"10.1016","volume":"308","author":[{"given":"Jeanette","family":"Woolard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Heal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Aspley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila M.","family":"Gardiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.103.061259_bib1","doi-asserted-by":"crossref","unstructured":"Birkenfeld AL, Schroeder CS, Boschmann M, Tank J, Franke G, Luft FC, Biaggioni I, Sharma AM, and Jordan J (2002) Paradoxical effect of sibutramine on autonomic cardiovascular function. Circulation 106: 2459-2465.","DOI":"10.1161\/01.CIR.0000036370.31856.73"},{"key":"10.1124\/jpet.103.061259_bib2","doi-asserted-by":"crossref","unstructured":"Buhler FR, Laragh JH, Baer L, Vaughan ED Jr., and Brunner HR (1972) Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. New Engl J Med 287: 1209-1214.","DOI":"10.1056\/NEJM197212142872401"},{"key":"10.1124\/jpet.103.061259_bib3","doi-asserted-by":"crossref","unstructured":"Cheetham SC, Viggers JA, Butler SA, Prow MR, and Heal DJ (1996) [3H]Nisoxetine - A radioligand for noradrenaline reuptake sites: correlation with inhibition of [3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments. Neuropharmacology 35: 63-70.","DOI":"10.1016\/0028-3908(95)00134-4"},{"key":"10.1124\/jpet.103.061259_bib4","doi-asserted-by":"crossref","unstructured":"Clapham JC, Arch JRS, and Tadayyon M (2001) Anti-obesity drugs: a critical review of current therapies and future opportunities. Pharmacol Ther 89: 81-121.","DOI":"10.1016\/S0163-7258(00)00105-4"},{"key":"10.1124\/jpet.103.061259_bib5","doi-asserted-by":"crossref","unstructured":"Connoley IP, Liu Y-L, Frost I, Reckless IP, Heal DJ, and Stock MJ (1999) Thermogenic effects of sibutramine and its metabolites. Br J Pharmacol 126: 1487-1495.","DOI":"10.1038\/sj.bjp.0702446"},{"key":"10.1124\/jpet.103.061259_bib6","doi-asserted-by":"crossref","unstructured":"Dunn WR and Gardiner SM (1995) Vascular structure in hypertension induced by NG-nitro-L-arginine methyl ester: methodological considerations for studies of small arteries. J Hypertens 13: 1217-1221.","DOI":"10.1097\/00004872-199510000-00017"},{"key":"10.1124\/jpet.103.061259_bib7","doi-asserted-by":"crossref","unstructured":"Dunn WR, Wallis SJ, and Gardiner SM (1998) Remodelling and enhanced myogenic tone in cerebral resistance arteries isolated from genetically hypertensive Brattleboro rats. J Vasc Res 35: 18-26.","DOI":"10.1159\/000025561"},{"key":"10.1124\/jpet.103.061259_bib8","unstructured":"Fantino M and Souquet AM (1995) Effects of metabolite 1 and 2 of sibutramine on the short-term control of food intake in the rat. Int J Obes 19: 145."},{"key":"10.1124\/jpet.103.061259_bib9","doi-asserted-by":"crossref","unstructured":"Fujioka K, Seaton TB, and Rowe E (2000) Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus. Diab Obes Metab 2: 175-187.","DOI":"10.1046\/j.1463-1326.2000.00081.x"},{"key":"10.1124\/jpet.103.061259_bib10","doi-asserted-by":"crossref","unstructured":"Gardiner SM and Bennett T (1988) Regional hemodynamic responses to adrenoceptor antagonism in conscious rats. Am J Physiol 255: H813-H824.","DOI":"10.1152\/ajpheart.1988.255.4.H813"},{"key":"10.1124\/jpet.103.061259_bib11","doi-asserted-by":"crossref","unstructured":"Gardiner SM, Compton AM, Kemp PA, Bennett T, Bose C, Foulkes R, and Hughes B (1990) Antagonist effects of human \u03b1-CGRP [8-37] on the in vivo regional haemodynamic actions of human \u03b1-CGRP. Biochem Biophys Res Commun 171: 938-943.","DOI":"10.1016\/0006-291X(90)90774-H"},{"key":"10.1124\/jpet.103.061259_bib12","doi-asserted-by":"crossref","unstructured":"Gardiner SM, Kemp PA, and Bennett T (1991) Effects of NG-nitro-L-arginine methyl ester on vasodilator responses to acetylcholine, 5\u2032-N-ethylcarboxamidoadenosine or salbutamol in conscious rats. Br J Pharmacol 103: 1725-1732.","DOI":"10.1111\/j.1476-5381.1991.tb09854.x"},{"key":"10.1124\/jpet.103.061259_bib13","doi-asserted-by":"crossref","unstructured":"Gardiner SM, Kemp PA, March JE, and Bennett T (1993) Regional haemodynamic effects of angiotensin II (3-8) in conscious rats. Br J Pharmacol 110: 159-162.","DOI":"10.1111\/j.1476-5381.1993.tb13786.x"},{"key":"10.1124\/jpet.103.061259_bib14","doi-asserted-by":"crossref","unstructured":"Gardiner SM, March JE, Kemp PA, and Bennett T (2002) Complex regional haemodynamic effects of anandamide in conscious rats. Br J Pharmacol 135: 1889-1896.","DOI":"10.1038\/sj.bjp.0704649"},{"key":"10.1124\/jpet.103.061259_bib15","doi-asserted-by":"crossref","unstructured":"Goldberg NR, Beuming T, Soyer OS, Goldstein RA, Weinstein H, and Javitch JA (2003) Probing conformational changes in neurotransmitter transporters: a structural context. Eur J Pharmacol 479: 3-12.","DOI":"10.1016\/j.ejphar.2003.08.052"},{"key":"10.1124\/jpet.103.061259_bib16","doi-asserted-by":"crossref","unstructured":"Guimaraes S and Moura D (2001) Vascular adrenoceptors: an update. Pharmacol Rev 53: 319-356.","DOI":"10.1016\/S0031-6997(24)01495-9"},{"key":"10.1124\/jpet.103.061259_bib17","doi-asserted-by":"crossref","unstructured":"Halford JCG, Wanninayake SCD, and Blundell JE (1998) Behavioural satiety sequence (BSS) for the diagnosis of drug action on food intake. Pharmacol Biochem Behav 61: 159-168.","DOI":"10.1016\/S0091-3057(98)00032-X"},{"key":"10.1124\/jpet.103.061259_bib18","doi-asserted-by":"crossref","unstructured":"Halpern W, Osol G, and Coy GS (1984) Mechanical behavior of pressurized in vitro prearteriolar vessels determined with a video system. Ann Biomed Eng 12: 463-479.","DOI":"10.1007\/BF02363917"},{"key":"10.1124\/jpet.103.061259_bib19","unstructured":"Heal DJ and Cheetham SC (1997) The pharmacology of sibutramine, the first serotonin and noradrenaline reuptake inhibitor to be developed for the treatment of obesity. Lett Pharmacol 11 (Suppl 10): 3-8."},{"key":"10.1124\/jpet.103.061259_bib20","doi-asserted-by":"crossref","unstructured":"Hind ID, Mangham JE, Ghani SP, Haddock RE, Garratt CJ, and Jones RW (1999) Sibutramine pharmacokinetics in young and elderly healthy subjects. Br J Clin Pharmacol 54: 847-849.","DOI":"10.1007\/s002280050565"},{"key":"10.1124\/jpet.103.061259_bib21","doi-asserted-by":"crossref","unstructured":"Jackson HC, Needham AM, Hutchins LJ, Mazurkiewicz SE, and Heal DJ (1997) Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat. Br J Pharmacol 121: 1758-1762.","DOI":"10.1038\/sj.bjp.0701312"},{"key":"10.1124\/jpet.103.061259_bib22","doi-asserted-by":"crossref","unstructured":"Janssen PJJM, Gardiner SM, Compton AM, and Bennett T (1991) Mechanisms contributing to the differential haemodynamic effects of bombesin and cholecystokinin in conscious, Long-Evans rats. Br J Pharmacol 102: 123-134.","DOI":"10.1111\/j.1476-5381.1991.tb12143.x"},{"key":"10.1124\/jpet.103.061259_bib23","doi-asserted-by":"crossref","unstructured":"King DJ and Devaney N (1988) Clinical pharmacology of sibutramine hydrochloride (BTS 54524), a new antidepressant, in healthy volunteers. Br J Clin Pharmacol 26: 607-611.","DOI":"10.1111\/j.1365-2125.1988.tb05303.x"},{"key":"10.1124\/jpet.103.061259_bib24","doi-asserted-by":"crossref","unstructured":"Kissebah AH and Krakower GR (1994) Regional adiposity and morbidity. Physiol Rev 74: 761-811.","DOI":"10.1152\/physrev.1994.74.4.761"},{"key":"10.1124\/jpet.103.061259_bib25","doi-asserted-by":"crossref","unstructured":"Kopelman PG (2000) Obesity as a medical problem. Nature (Lond) 404: 635-643.","DOI":"10.1038\/35007508"},{"key":"10.1124\/jpet.103.061259_bib26","doi-asserted-by":"crossref","unstructured":"Luque CA and Rey JA (2002) The discovery and status of sibutramine as an anti-obesity drug. Eur J Pharmacol 440: 119-128.","DOI":"10.1016\/S0014-2999(02)01423-1"},{"key":"10.1124\/jpet.103.061259_bib27","doi-asserted-by":"crossref","unstructured":"Luscombe GP, Hopcroft RH, Thomas PC, and Buckett WR (1989) The contribution of metabolites to the rapid and potent down-regulation of rat cortical \u03b2-adrenoceptors by the putative antidepressant, sibutramine hydrochloride. Neuropharmacology 28: 129-134.","DOI":"10.1016\/0028-3908(89)90048-8"},{"key":"10.1124\/jpet.103.061259_bib28","doi-asserted-by":"crossref","unstructured":"Luscombe GP, Slater NA, Lyons MB, Wynne RD, Scheinbaum ML, and Buckett WR (1990) Effect on radiolabelled-monoamine uptake in vitro of plasma taken from healthy volunteers administered the antidepressant sibutramine HCl. Psychopharmacology 100: 345-349.","DOI":"10.1007\/BF02244604"},{"key":"10.1124\/jpet.103.061259_bib29","doi-asserted-by":"crossref","unstructured":"Rowley HL, Butler SA, Prow MR, Dykes SG, Aspley S, Kilpatrick IC, and Heal DJ (2000) Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats. Synapse 38: 167-176.","DOI":"10.1002\/1098-2396(200011)38:2<167::AID-SYN8>3.0.CO;2-W"},{"key":"10.1124\/jpet.103.061259_bib30","doi-asserted-by":"crossref","unstructured":"Schroeder C, Tank J, Boschmann M, Diedrich A, Sharma AM, Baggioni I, Luft C, and Jordan J (2002) Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance. Circulation 105: 347-353.","DOI":"10.1161\/hc0302.102597"},{"key":"10.1124\/jpet.103.061259_bib31","unstructured":"Stock MJ (1997) Sibutramine: a review of the pharmacology of a novel anti-obesity agent. Int J Obes 21: S25-S29."},{"key":"10.1124\/jpet.103.061259_bib32","doi-asserted-by":"crossref","unstructured":"Tank J, Schroeder C, Diedrich A, Szczech E, Haertter S, Sharma AM, Luft F, and Jordan J (2003) Selective impairment in sympathetic vasomotor control with norepinephrine transporter inhibition. Circulation 107: 2949-2954.","DOI":"10.1161\/01.CIR.0000072786.99163.FE"},{"key":"10.1124\/jpet.103.061259_bib33","doi-asserted-by":"crossref","unstructured":"Theodorsson-Norheim E (1987) Friedman and Quade tests: BASIC computer program to perform nonparametric two-way analysis of variance and multiple comparisons on ranks of several related samples. Comput Biol Med 17: 85-99.","DOI":"10.1016\/0010-4825(87)90003-5"},{"key":"10.1124\/jpet.103.061259_bib34","doi-asserted-by":"crossref","unstructured":"Woolard J, Gardiner SM, Aspley S, and Bennett T (2001) Regional haemodynamic responses to fluoxetine or nisoxetine in conscious Sprague-Dawley rats. Br J Pharmacol 133 (Suppl): 27P.","DOI":"10.1038\/sj.bjp.0704100"},{"key":"10.1124\/jpet.103.061259_bib35","unstructured":"Woolard J, Gardiner SM, Aspley S, and Bennett T (2002) Regional haemodynamic effects of the 5-HT and noradrenaline re-uptake inhibitor, sibutramine, in conscious rats: effects of \u03b1- or \u03b2-adrenoceptor antagonism. Br J Pharmacol 137 (Suppl): 76P."}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652431225X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652431225X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.103.061259","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:48:24Z","timestamp":1739998104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652431225X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S002235652431225X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.103.061259","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2004,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute Cardiovascular Effects of Sibutramine in Conscious Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.103.061259","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2004 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}